Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer.

Sung Gwe AhnSeon-Kyu KimJonathan H ShepherdYoon Jin ChaSoong June BaeChungyeul KimJoon JeongCharles M Perou

Published in: Breast cancer research and treatment (2021)

We provide multi-faceted evidence that SP142 PDL1-positive TNBC have immuno-genomic features characterized as highly lymphocyte-infiltrated and a relatively favorable survival.

Keyphrases

copy number
poor prognosis
peripheral blood
binding protein
genome wide